Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Diabetic Peripheral Neuropathy - Overview
Diabetic Peripheral Neuropathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Diabetic Peripheral Neuropathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Diabetic Peripheral Neuropathy - Companies Involved in Therapeutics Development
Achelios Therapeutics Inc
Applied Therapeutics Inc
Bionevia Pharmaceuticals
Bristol-Myers Squibb Co
Calchan Ltd
Celularity Inc
Commence Bio Inc
CSPC Pharmaceutical Group Ltd
Eli Lilly and Co
Exodos Life Sciences Limited Partnership
GNT Pharma Co Ltd
Grunenthal GmbH
Immune Pharmaceuticals Inc
Ion Channel Pharmacology LLC
Jiangsu Aosaikang Pharmaceutical Co Ltd
Korea United Pharm Inc
Medifron DBT Co Ltd
Mitsubishi Tabe Pharma Corp
Pfizer Inc
Praetego Inc
Reata Pharmaceuticals Inc
Seneca Biopharma Inc
Sonnet BioTherapeutics Holdings Inc
Sphaera Pharma Pte Ltd
Winsantor Inc
YD Life Science Co
Zhejiang Pharmaceutical Co Ltd
Diabetic Peripheral Neuropathy - Drug Profiles
(amitriptyline + ketamine hydrochloride) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
(diclofec sodium + triclocarban) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AAD-2004 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Diabetic Peripheral Neuropathy - Dormant Projects
Diabetic Peripheral Neuropathy - Discontinued Products
Diabetic Peripheral Neuropathy - Product Development Milestones
Featured News & Press Releases
Aug 16, 2018: Regecy Pharmaceuticals announces patent issuance for Ricolinostat to treat diabetic peripheral neuropathy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Diabetic Peripheral Neuropathy, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Diabetic Peripheral Neuropathy, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Achelios Therapeutics Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Applied Therapeutics Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Bionevia Pharmaceuticals, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Bristol-Myers Squibb Co, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Calchan Ltd, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Celularity Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Commence Bio Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by CSPC Pharmaceutical Group Ltd, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Eli Lilly and Co, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Exodos Life Sciences Limited Partnership, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by GNT Pharma Co Ltd, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Grunenthal GmbH, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Immune Pharmaceuticals Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Ion Channel Pharmacology LLC, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Jiangsu Aosaikang Pharmaceutical Co Ltd, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Korea United Pharm Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Medifron DBT Co Ltd, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Mitsubishi Tanabe Pharma Corp, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Pfizer Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Praetego Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Reata Pharmaceuticals Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Seneca Biopharma Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Sonnet BioTherapeutics Holdings Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Sphaera Pharma Pte Ltd, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Winsantor Inc, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by YD Life Science Co, H2 2020
Diabetic Peripheral Neuropathy - Pipeline by Zhejiang Pharmaceutical Co Ltd, H2 2020
Diabetic Peripheral Neuropathy - Dormant Projects, H2 2020
Diabetic Peripheral Neuropathy - Discontinued Products, H2 2020